首页> 美国卫生研究院文献>other >Combined megaplex TCR isolation and SMART-based real-time quantitation methods for quantitating antigen-specific T cell clones in mycobacterial infection
【2h】

Combined megaplex TCR isolation and SMART-based real-time quantitation methods for quantitating antigen-specific T cell clones in mycobacterial infection

机译:结合的megaplex TCR分离和基于SMART的实时定量方法可用于定量分枝杆菌感染中的抗原特异性T细胞克隆

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite recent advances in measuring cellular immune responses, the quantitation of antigen-specific T cell clones in infections or diseases remains challenging. Here, we employed combined megaplex TCR isolation and SMART-based real-time quantitation methods to quantitate numerous antigen-specific T cell clones using limited amounts of specimens. The megaplex TCR isolation covered the repertoire comprised of recombinants from 24 Vβ families and 13 Jβ segments, and allowed us to isolate TCR VDJ clonotypic sequences from one or many PPD-specific IFNγ-producing T cells that were purified by flow cytometry sorting. The SMART amplification technique was then validated for its capacity to proportionally enrich cellular TCR mRNA/cDNA for real-time quantitation of large numbers of T cell clones. SMART amplified cDNA was shown to maintain relative expression levels of TCR genes when compared to unamplified cDNA. While the SMART-based real-time quantitative PCR conferred a detection limit of 10−5 to 10−6 antigen-specific T cells, the clonotypic primers specifically amplified and quantitated the target clone TCR but discriminated other clones that differed by ≥2 bases in the DJ regions. Furthermore, the combined megaplex TCR isolation and SMART-based real-time quantiation methods allowed us to quantitate large numbers of PPD-specific IFNγ-producing T cell clones using as few as 2×106 PBMC collected weekly after mycobacterial infection. This assay system may be useful for studies of antigen-specific T cell clones in tumors, autoimmune and infectious diseases.
机译:尽管最近在测量细胞免疫反应方面取得了进展,但是在感染或疾病中对抗原特异性T细胞克隆的定量分析仍具有挑战性。在这里,我们采用了基于megaplex TCR分离和基于SMART的实时定量分析相结合的方法,使用有限的标本对众多抗原特异性T细胞克隆进行了定量。 megaplex TCR分离涵盖了由来自24个Vβ家族和13个Jβ片段的重组体组成的库,并使我们能够从一种或多种PPD特异性产生IFNγ的T细胞中分离TCR VDJ克隆型序列,这些T细胞通过流式细胞仪分选纯化。然后验证SMART扩增技术具有按比例富集细胞TCR mRNA / cDNA以便实时定量大量T细胞克隆的能力。与未扩增的cDNA相比,SMART扩增的cDNA显示出维持TCR基因的相对表达水平。尽管基于SMART的实时定量PCR的检测限为10 -5 至10 -6 抗原特异性T细胞,但克隆型引物可特异性扩增并定量目标克隆TCR,但区分了DJ区中相差≥2个碱基的其他克隆。此外,结合兆链TCR分离和基于SMART的实时定量方法,我们可以使用每周收集的仅2×10 6 PBMC来定量大量产生PPD特异性IFNγ的T细胞克隆。分枝杆菌感染后。该测定系统可用于研究肿瘤,自身免疫和感染性疾病中的抗原特异性T细胞克隆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号